Skip to main content
. 2019 Dec 5;11:185. doi: 10.1186/s13148-019-0766-2

Table 2.

Initial histopathological diagnoses

Tumor type (n = 55) N %
Diffuse glioma Diffuse astrocytoma, IDH mutant 4 7
Diffuse astrocytoma, IDH1 (R132H) negative 2 4
Anaplastic astrocytoma, IDH mutant 2 4
Anaplastic astrocytoma, IDH1 (R132H) negative 3 5
Oligodendroglioma, IDH1 (R132H) negative, 1p/19q co-deleted 2 4
Anaplastic oligodendroglioma, IDH1 (R132H) negative, 1p/19q co-deleted 3 5
Glioblastoma, IDH1 (R132H) negative 11 20
Glioma NOS 3 5
Low grade glioma 1 2
Diffuse low grade glioma 1 2
Other astrocytic Pilocytic astrocytoma 1 2
PXA 1 2
Anaplastic PXA 2 4
Ependymal Subependymoma 2 4
Ependymoma 1 2
Anaplastic ependymoma 3 5
Choroid plexus Atypical choroid plexus papilloma 1 2
Neuronal Dysembryoplastic neuroepithelial tumor 1 2
Ganglioglioma variant 2 4
Embryonal Medulloblastoma 3 5
Nerves Schwannoma 1 2
Meningioma Atypical meningioma 1 2
Mesenchymal SFT/hemangiopericytoma 1 2
Metastatic Melanocytic lesion NOS 1 2
Metastatic high-grade NE neoplasm 1 2
Non-neoplastic Meningioangiomatosis 1 2

NOS not otherwise specified, PXA pleomorphic xanthoastrocytoma, SFT solitary fibrous tumor, NE neuroendocrine